ArticleInternational journal of clinical and experimental medicine2012

Development of targeted therapy for a broad spectrum of cancers (pancreatic cancer, ovarian cancer, glioblastoma and HCC) mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences.

Doron Amit et al.PubMed ↗Full text ↗

No numbers read from the abstract.